Merosure O Dry Syrup Delicious Orange

Introduction

Merosure O is a prescription medication that contains the active ingredient Faropenem. It is available in the form of a dry syrup and is used to treat certain bacterial infections.

Uses

Merosure O is prescribed to treat a variety of bacterial infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and certain types of pneumonia. It is effective against a wide range of bacteria, including both Gram-positive and Gram-negative bacteria.

Dosage and Administration

The dosage of Merosure O will depend on the specific condition being treated, as well as the age and weight of the patient. Follow the instructions provided by your healthcare provider or the information on the prescription label. The dry syrup should be reconstituted with the recommended amount of water before administration. Shake well before use. The medication is usually taken orally, and take it at evenly spaced intervals to maintain a constant level in the blood.

Mechanism of Action

Faropenem, the active ingredient in Merosure O, belongs to the class of medications known as carbapenem antibiotics. It works by inhibiting the growth of bacteria and interfering with their ability to form cell walls. This ultimately leads to the death of the bacteria and helps in clearing the infection.

Side Effects

Common side effects may include nausea, vomiting, diarrhea, stomach pain, headache, and skin rash. These side effects are usually mild and go away on their own. However, if you experience any severe or persistent side effects, such as severe diarrhea, abdominal cramps, or an allergic reaction, seek medical attention immediately.

Drug Interactions

Merosure O may interact with certain medications, including probenecid, which can increase the levels of Faropenem in the blood. Inform your healthcare provider about all the medications you are currently taking, including prescription drugs, over-the-counter medications, and herbal supplements, to avoid any potential drug interactions.

Precautions

Before taking Merosure O, inform your healthcare provider if you have any allergies, especially to antibiotics. Mention any other medications you are taking, as well as any medical conditions you have, such as kidney or liver disease. Merosure O should be used with caution in pregnant women, and it is not recommended for use during breastfeeding.

Storage

Merosure O should be stored in a cool, dry place, away from direct sunlight and heat. It should be kept out of the reach of children and pets. Do not use the medication if it has expired or if the packaging is damaged.

Patient Tips

• Take Merosure O exactly as prescribed by your healthcare provider.
• Finish the full course of treatment, even if you start feeling better before completing the medication.
• If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule.
• If you have any questions or concerns about the medication, don’t hesitate to consult your healthcare provider.
• maintain good hygiene practices and follow any additional precautions recommended by your healthcare provider to prevent the spread of infections.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Orapem (faropenem medoxomil): What is it and is it FDA approved? (Drugs.com) [Accessed 17 Jun. 2024] (online) Available at:
• Gettig JP, Crank CW, Philbrick AH. Faropenem medoxomil. Ann Pharmacother. 2008 Jan;42(1):80-90. doi: 10.1345/aph.1G232. Epub 2007 Dec 19. [Accessed 15 Jun. 2024] Available at:
• Lucic A, Hinchliffe P, Malla TR, Tooke CL, Brem J, Calvopiña K, Lohans CT, Rabe P, McDonough MA, Armistead T, Orville AM, Spencer J, Schofield CJ. Faropenem reacts with serine and metallo-beta-lactamases to give multiple products. Eur J Med Chem. 2021 Apr 5;215:113257. doi: 10.1016/j.ejmech.2021.113257. Epub 2021 Feb 9. [Accessed 2 Jun. 2024] Available at:
• Gandra S, Choi J, McElvania E, Green SJ, Harazin M, Thomson RB, Dantas G, Singh KS, Das S. Faropenem resistance causes in vitro cross-resistance to carbapenems in ESBL-producing Escherichia coli. Int J Antimicrob Agents. 2020 Mar;55(3):105902. doi: 10.1016/j.ijantimicag.2020.105902. Epub 2020 Jan 17. [Accessed 0 Jun. 2024] Available at: